Showing results (151-160 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent usedArnold Pinter, Paul Dorian, Miney Paquette, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitorXiaotao Li, Yanmei Du, Yanfang Du, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2007
Pathophysiological basis of right ventricular remodelingMarcus Kret, Rohit AroraJournal of Cardiovascular Pharmacology and Therapeutics|May 15, 2007
Effects of rotigaptide, a gap junction modifier, on defibrillation energy and resuscitation from cardiac arrest in rabbitsJing-quan Zhong, Gabriel Laurent, Petsy Pui-Sze So, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 16, 2007
A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both?Ernst R Schwarz, Praveen Jammula, Rajiv Gupta, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 16, 2007
Evolving perspectives on clopidogrel in the treatment of ischemic strokePhilip Gorelick, Oksana Sechenova, Charles H HennekensJournal of Cardiovascular Pharmacology and Therapeutics|May 17, 2006
Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidenceSofia G Tsouli, Evagelos N Liberopoulos, Dimitrios N Kiortsis, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 17, 2006
Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venorutonMaria Rosaria Cesarone, Gianni Belcaro, Luciano Pellegrini, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 19, 2007
Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trialsSandeep A Saha, Janos Molnar, Rohit R AroraJournal of Cardiovascular Pharmacology and Therapeutics|September 19, 2007
Improvement of cardiac function persists long term with medical therapy for left ventricular systolic dysfunctionDavid Chen, Richard Chang, Branavan Umakanthan, et al.Pageof 129